ADVANCED PATHOPHYSIOLOGY
HESI FINAL EXAMINATION
Comprehensive Graduate-Level Disease Mechanism &
Clinical Correlation Competency Assessment
2025/2026 Edition
────────────────────────────────────────
Elsevier Evolve / HESI Advanced Pathophysiology Module
AACN DNP Essentials Alignment
McCance & Huether: Pathophysiology (9th ed.) | Porth's Pathophysiology (11th ed.)
75 Multiple-Choice Questions | 105 Minutes | Passing Score: 850 HESI / 75–80%
All Questions with Detailed Rationales | 100% Verified | Graded A+
Graduate Nursing Program
Advanced Pathophysiology Competency Assessment
,Abstract
This practice examination presents a comprehensive competency assessment designed for graduate
nursing students preparing for the Advanced Pathophysiology HESI Final Examination. Aligned with the
Elsevier Evolve HESI Advanced Pathophysiology module, the McCance and Huether Pathophysiology
textbook (9th edition), Porth's Pathophysiology (11th edition), and the AACN Essentials for Doctoral Nursing
Education, this examination consists of exactly 75 multiple-choice questions distributed across seven critical
domains. The domains include cellular and genetic pathophysiology, inflammatory and immune responses,
neurological and endocrine disorders, cardiovascular and pulmonary pathophysiology, renal, gastrointestinal
and hematologic mechanisms, oncology and infectious disease pathophysiology, and clinical correlation with
scenario-based application. Each question is accompanied by a detailed rationale explaining the underlying
pathophysiologic mechanism, molecular or cellular pathway, and clinical correlation, serving both as an
assessment tool and a study resource. This examination reflects the 2025/2026 HESI test blueprint and
graduate-level pathophysiology competency standards.
Keywords: Advanced Pathophysiology, HESI Examination, Cellular Injury, Immune Dysregulation,
Cardiovascular Pathophysiology, Neuroendocrine Disorders, Clinical Correlation, Disease Mechanisms,
Graduate Nursing Education
Introduction
The Advanced Pathophysiology HESI Final Examination evaluates graduate nursing students'
mastery of complex disease mechanisms, cellular and molecular pathways, and the integration of
pathophysiologic principles with clinical manifestations. This competency assessment is a critical milestone
in advanced practice nursing education, ensuring that students possess the foundational knowledge
necessary for evidence-based clinical decision-making, differential diagnosis, and therapeutic reasoning
across diverse patient populations and disease conditions.
This practice examination is structured to mirror the official HESI Advanced Pathophysiology Final
in both content distribution and cognitive complexity. The 75 multiple-choice questions span seven domains
that encompass the breadth of advanced pathophysiology, from cellular injury mechanisms and genetic
alterations through multi-organ system dysfunction and integrated clinical scenarios. Questions include
standard multiple-choice items, disease mechanism application vignettes, pathophysiologic-to-clinical
manifestation mapping items, and advanced clinical judgment scenarios requiring multi-system integration.
The recommended testing time is 105 minutes, and a passing score of 850 on the HESI scale or 75 to
80 percent is typically required for course competency. Students are encouraged to approach this
examination with the same rigor as the official assessment, using the detailed rationales provided for each
question to reinforce mechanistic understanding and identify areas requiring further study. This examination
is aligned with the 2025/2026 HESI test blueprint and should be used in conjunction with current Elsevier
Evolve resources.
Examination Structure
The following table summarizes the domain structure and question distribution for this examination.
Domain Questions Key Topics Weight
Cellular & Genetic 10 Cellular Adaptations, 13%
Pathophysiology Apoptosis/Necrosis,
Epigenetics, Gene
Expression
Inflammatory & 12 Innate/Adaptive 16%
Immune Responses Immunity,
Hypersensitivity,
Autoimmunity, Chronic
Inflammation
Neurological & 11 Neuronal Injury, 15%
Endocrine Disorders Neurotransmitter
Imbalances, HPA Axis,
Diabetes/Thyroid/Adrenal
Cardiovascular & 13 Atherosclerosis, 17%
Pulmonary Hemodynamics,
, Pathophysiology Arrhythmias, V/Q
Mismatch, COPD/Asthma
Renal, Gastrointestinal 12 Glomerular Dysfunction, 16%
& Hematologic Hepatic Failure,
Coagulopathy, Acid-Base
Disorders
Oncology & Infectious 9 Carcinogenesis, Tumor 12%
Disease Staging, Antimicrobial
Resistance, Sepsis
Pathways
Clinical Correlation & 8 Biomarker Interpretation, 11%
Scenario Application Differential Diagnosis,
Multi-System Integration
Total: 75 Questions | Testing Time: 105 Minutes | Passing Score: 850 HESI / 75–80%
Examination Questions
Domain 1: Cellular & Genetic Pathophysiology
This domain evaluates understanding of cellular injury mechanisms, adaptive responses, apoptotic and
necrotic pathways, epigenetic modifications, and genetic alterations that underlie disease processes.
Questions require integration of molecular biology with clinical manifestations to demonstrate mechanistic
reasoning at the graduate level.
Q1. A researcher observes that cells exposed to chronic hypoxia undergo a change in which
they transition from aerobic to anaerobic metabolism. Which cellular adaptation best
describes this phenomenon?
A. Atrophy
B. Metaplasia
C. Hyperplasia
D. Ischemic cellular injury with metabolic shift
Correct Answer: D
Rationale: Chronic hypoxia causes ischemic cellular injury characterized by a shift from aerobic oxidative
phosphorylation to anaerobic glycolysis. This metabolic shift results in decreased ATP production, lactic
acid accumulation, and intracellular acidosis. Atrophy refers to decrease in cell size, metaplasia is
replacement of one cell type with another, and hyperplasia is increased cell number—none of which
specifically describe the metabolic reprogramming seen in hypoxic injury.
Q2. Which of the following is a key distinction between apoptosis and necrosis?
A. Apoptosis involves cellular swelling; necrosis involves cell shrinkage
B. Apoptosis is a programmed, energy-dependent process; necrosis is unregulated cell
death with membrane rupture
C. Necrosis does not trigger inflammation; apoptosis does
D. Apoptosis only occurs in pathological conditions
Correct Answer: B
Rationale: Apoptosis is an active, programmed, energy-dependent process characterized by cell shrinkage,
chromatin condensation, and formation of apoptotic bodies that are phagocytosed without inflammation.
Necrosis is unregulated cell death involving cellular swelling, membrane rupture, and release of
intracellular contents that trigger inflammation. Apoptosis occurs in both physiological and pathological
conditions, making option D incorrect. The inflammatory and morphological characteristics in options A
and C are reversed.
Q3. A patient with sickle cell disease has a point mutation in the beta-globin gene resulting in
substitution of valine for glutamic acid at position 6. This type of mutation is classified as:
A. Frameshift mutation
HESI FINAL EXAMINATION
Comprehensive Graduate-Level Disease Mechanism &
Clinical Correlation Competency Assessment
2025/2026 Edition
────────────────────────────────────────
Elsevier Evolve / HESI Advanced Pathophysiology Module
AACN DNP Essentials Alignment
McCance & Huether: Pathophysiology (9th ed.) | Porth's Pathophysiology (11th ed.)
75 Multiple-Choice Questions | 105 Minutes | Passing Score: 850 HESI / 75–80%
All Questions with Detailed Rationales | 100% Verified | Graded A+
Graduate Nursing Program
Advanced Pathophysiology Competency Assessment
,Abstract
This practice examination presents a comprehensive competency assessment designed for graduate
nursing students preparing for the Advanced Pathophysiology HESI Final Examination. Aligned with the
Elsevier Evolve HESI Advanced Pathophysiology module, the McCance and Huether Pathophysiology
textbook (9th edition), Porth's Pathophysiology (11th edition), and the AACN Essentials for Doctoral Nursing
Education, this examination consists of exactly 75 multiple-choice questions distributed across seven critical
domains. The domains include cellular and genetic pathophysiology, inflammatory and immune responses,
neurological and endocrine disorders, cardiovascular and pulmonary pathophysiology, renal, gastrointestinal
and hematologic mechanisms, oncology and infectious disease pathophysiology, and clinical correlation with
scenario-based application. Each question is accompanied by a detailed rationale explaining the underlying
pathophysiologic mechanism, molecular or cellular pathway, and clinical correlation, serving both as an
assessment tool and a study resource. This examination reflects the 2025/2026 HESI test blueprint and
graduate-level pathophysiology competency standards.
Keywords: Advanced Pathophysiology, HESI Examination, Cellular Injury, Immune Dysregulation,
Cardiovascular Pathophysiology, Neuroendocrine Disorders, Clinical Correlation, Disease Mechanisms,
Graduate Nursing Education
Introduction
The Advanced Pathophysiology HESI Final Examination evaluates graduate nursing students'
mastery of complex disease mechanisms, cellular and molecular pathways, and the integration of
pathophysiologic principles with clinical manifestations. This competency assessment is a critical milestone
in advanced practice nursing education, ensuring that students possess the foundational knowledge
necessary for evidence-based clinical decision-making, differential diagnosis, and therapeutic reasoning
across diverse patient populations and disease conditions.
This practice examination is structured to mirror the official HESI Advanced Pathophysiology Final
in both content distribution and cognitive complexity. The 75 multiple-choice questions span seven domains
that encompass the breadth of advanced pathophysiology, from cellular injury mechanisms and genetic
alterations through multi-organ system dysfunction and integrated clinical scenarios. Questions include
standard multiple-choice items, disease mechanism application vignettes, pathophysiologic-to-clinical
manifestation mapping items, and advanced clinical judgment scenarios requiring multi-system integration.
The recommended testing time is 105 minutes, and a passing score of 850 on the HESI scale or 75 to
80 percent is typically required for course competency. Students are encouraged to approach this
examination with the same rigor as the official assessment, using the detailed rationales provided for each
question to reinforce mechanistic understanding and identify areas requiring further study. This examination
is aligned with the 2025/2026 HESI test blueprint and should be used in conjunction with current Elsevier
Evolve resources.
Examination Structure
The following table summarizes the domain structure and question distribution for this examination.
Domain Questions Key Topics Weight
Cellular & Genetic 10 Cellular Adaptations, 13%
Pathophysiology Apoptosis/Necrosis,
Epigenetics, Gene
Expression
Inflammatory & 12 Innate/Adaptive 16%
Immune Responses Immunity,
Hypersensitivity,
Autoimmunity, Chronic
Inflammation
Neurological & 11 Neuronal Injury, 15%
Endocrine Disorders Neurotransmitter
Imbalances, HPA Axis,
Diabetes/Thyroid/Adrenal
Cardiovascular & 13 Atherosclerosis, 17%
Pulmonary Hemodynamics,
, Pathophysiology Arrhythmias, V/Q
Mismatch, COPD/Asthma
Renal, Gastrointestinal 12 Glomerular Dysfunction, 16%
& Hematologic Hepatic Failure,
Coagulopathy, Acid-Base
Disorders
Oncology & Infectious 9 Carcinogenesis, Tumor 12%
Disease Staging, Antimicrobial
Resistance, Sepsis
Pathways
Clinical Correlation & 8 Biomarker Interpretation, 11%
Scenario Application Differential Diagnosis,
Multi-System Integration
Total: 75 Questions | Testing Time: 105 Minutes | Passing Score: 850 HESI / 75–80%
Examination Questions
Domain 1: Cellular & Genetic Pathophysiology
This domain evaluates understanding of cellular injury mechanisms, adaptive responses, apoptotic and
necrotic pathways, epigenetic modifications, and genetic alterations that underlie disease processes.
Questions require integration of molecular biology with clinical manifestations to demonstrate mechanistic
reasoning at the graduate level.
Q1. A researcher observes that cells exposed to chronic hypoxia undergo a change in which
they transition from aerobic to anaerobic metabolism. Which cellular adaptation best
describes this phenomenon?
A. Atrophy
B. Metaplasia
C. Hyperplasia
D. Ischemic cellular injury with metabolic shift
Correct Answer: D
Rationale: Chronic hypoxia causes ischemic cellular injury characterized by a shift from aerobic oxidative
phosphorylation to anaerobic glycolysis. This metabolic shift results in decreased ATP production, lactic
acid accumulation, and intracellular acidosis. Atrophy refers to decrease in cell size, metaplasia is
replacement of one cell type with another, and hyperplasia is increased cell number—none of which
specifically describe the metabolic reprogramming seen in hypoxic injury.
Q2. Which of the following is a key distinction between apoptosis and necrosis?
A. Apoptosis involves cellular swelling; necrosis involves cell shrinkage
B. Apoptosis is a programmed, energy-dependent process; necrosis is unregulated cell
death with membrane rupture
C. Necrosis does not trigger inflammation; apoptosis does
D. Apoptosis only occurs in pathological conditions
Correct Answer: B
Rationale: Apoptosis is an active, programmed, energy-dependent process characterized by cell shrinkage,
chromatin condensation, and formation of apoptotic bodies that are phagocytosed without inflammation.
Necrosis is unregulated cell death involving cellular swelling, membrane rupture, and release of
intracellular contents that trigger inflammation. Apoptosis occurs in both physiological and pathological
conditions, making option D incorrect. The inflammatory and morphological characteristics in options A
and C are reversed.
Q3. A patient with sickle cell disease has a point mutation in the beta-globin gene resulting in
substitution of valine for glutamic acid at position 6. This type of mutation is classified as:
A. Frameshift mutation
